© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Hims & Hers Health, Inc. (HIMS) stock surged +8.50%, trading at $22.24 on NYSE, up from the previous close of $20.50. The stock opened at $20.41, fluctuating between $20.09 and $22.28 in the recent session.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Employees | 1046 |
Beta | 1.051 |
Sales or Revenue | $872.00M |
5Y Sales Change% | 9.506% |
Fiscal Year Ends | December |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
Hims & Hers Health, Inc. (NYSE: HIMS) stock price is $22.24 in the last trading session. During the trading session, HIMS stock reached the peak price of $22.28 while $20.09 was the lowest point it dropped to. The percentage change in HIMS stock occurred in the recent session was 8.5% while the dollar amount for the price change in HIMS stock was $1.74.
The NYSE listed HIMS is part of Household & Personal Products industry that operates in the broader Consumer Defensive sector. Hims & Hers Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Melissa Baird
Chief Operations Officer
Mr. Brian O'Shaughnessy
Chief Communications Officer
Dr. Patrick Carroll M.D.
Chief Medical Officer, Member of Medical Advisory Board & Director
Dr. Aimee Paik FAAD, M.D.
Senior Vice President & Member of Medical Advisory Board
Mr. Andrew Dudum
Co-Founder, Chairman & Chief Executive Officer
Mr. Yemi Okupe
Chief Financial Officer
Ms. Soleil Teubner Boughton
Chief Legal Officer & Corporation Sec.
Mr. Mike Chi
Chief Marketing Officer
Ms. Amee Parekh
Senior Vice President of HR
Ms. Irene A. Becklund
Senior Vice President, Controller & Principal Accounting Officer
Mr. Jonathan Spitzer C.F.A.
Vice President of Investor Relations
HIMS's closing price is 262.83% higher than its 52-week low of $5.65 where as its distance from 52-week high of $25.74 is -20.36%.
Number of HIMS employees currently stands at 1,046.
Official Website of HIMS is: https://www.forhims.com
HIMS could be contacted at phone 415 851 0195 and can also be accessed through its website. HIMS operates from 2269 Chestnut Street, San Francisco, CA 94123, United States.
HIMS stock volume for the day was 8.29M shares. The average number of HIMS shares traded daily for last 3 months was 9.78M.
The market value of HIMS currently stands at $4.63B with its latest stock price at $22.24 and 208.07M of its shares outstanding.